ACCF/AHA New Insights Into the Methodology of Performance Measurement
[...]the implementation and analysis of performance measures are discussed, including the use of composite measures and attribution as the foundation for a continually growing and improving healthcare system. New Insights Into the Selection of Possible Performance Measures Abbreviations Used Through...
Gespeichert in:
Veröffentlicht in: | Journal of the American College of Cardiology 2010-11, Vol.56 (21), p.1767-1782 |
---|---|
Hauptverfasser: | , , , , , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | [...]the implementation and analysis of performance measures are discussed, including the use of composite measures and attribution as the foundation for a continually growing and improving healthcare system. New Insights Into the Selection of Possible Performance Measures Abbreviations Used Throughout the Report AMI, acute myocardial infarction CMS, Centers for Medicare and Medicaid Services D2B, American College of Cardiology Foundation Door-to-Balloon Alliance EMRs, electronic medical records ICER, incremental cost-effectiveness ratio INR, international normalized ratio IOM, Institute of Medicine MI, myocardial infarction NCQA, National Committee for Quality Assurance NQF, National Quality Forum PCI, percutaneous coronary intervention PCPI, American Medical Association-Physician Consortium for Performance Improvement Strength of Evidence Initial recommendations for construction of a performance measurement set (1) involved: 1) evaluating the strength of evidence supporting a potential performance measure, 2) defining the clinical significance of the outcome most likely to be achieved by adherence to a performance measure, and 3) assessing the magnitude of the association between adherence to the potential performance measure and a clinically important outcome. Because there can be strong financial incentives for a manufacturer to have its diagnostic or therapeutic products included in a performance measure, a clearly articulated approach to the selection of performance measures is needed. |
---|---|
ISSN: | 0735-1097 1558-3597 |
DOI: | 10.1016/j.jacc.2010.09.009 |